Antibody responses to endemic coronaviruses modulate COVID-19 convalescent plasma functionality.
Ontology highlight
ABSTRACT: COVID-19 convalescent plasma, particularly plasma with high-titer SARS-CoV-2 (CoV2) antibodies, has been successfully used for treatment of COVID-19. The functionality of convalescent plasma varies greatly, but the association of antibody epitope specificities with plasma functionality remains uncharacterized. We assessed antibody functionality and reactivities to peptides across the CoV2 and the four endemic human coronavirus (HCoV) genomes in 126 COVID-19 convalescent plasma donations. We found strong correlation between plasma functionality and polyclonal antibody targeting of CoV2 spike protein peptides. Antibody reactivity to many HCoV spike peptides also displayed strong correlation with plasma functionality, including pan-coronavirus cross-reactive epitopes located in a conserved re
SUBMITTER: Morgenlander W
PROVIDER: S-EPMC7755150 | biostudies-literature | 2020 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA